Search

NHMRC’s goal is to support the highest quality research that will lead to improvements in health over the short or long term. Peer review by independent experts is used to identify well-designed feasible projects that address a significant question and are undertaken by researchers with demonstrated capacity to perform high-quality research.

In providing a safe and healthy workplace, we provide an environment in which we can all effectively contribute to achieving community and business outcomes.

MRFF – Emerging Priorities and Consumer Driver Research Initiative – 2024 Alcohol and Other Drugs Grant Opportunity

NHMRC's Research Quality Steering Committee was established to provide advice about enhancing the quality of NHMRC-funded research.

The guidelines are produced by the National Health and Medical Research Council (NHMRC) in collaboration with the Australian Commission on Safety and Quality in Healthcare, and are published on the MAGICapp platform.

This report Promoting social and emotional development and wellbeing of infants in pregnancy and the first year of life: a NHMRC report on the evidence summarises findings of the evaluation of evidence on the effectiveness of interventions delivered in pregnancy or the first postpartum year.

This guide supports the implementation of the Australian code for the care and use of animals for scientific purposes 8th edition (2013) by providing advice about how the specific and unique needs of Australian native mammals can be met when these animals are used for scientific purposes. It provides information for investigators, institutions, animal ethics committees and all those involved in the care and use of Australian native mammals for scientific purposes.Notice: This publication is more than 5 years old and may no longer reflect current evidence or best practice.

The Guidelines to promote the wellbeing of animals used for scientific purposes: The assessment and alleviation of pain and distress in research animals (2008) provide guidance on how to support and safeguard the wellbeing of animals used for scientific purposes.Notice: This publication is more than five years old and may no longer reflect current evidence or best practice.

Road map II: A strategic framework for improving the health of Aboriginal and Torres Strait Islander people through research will be used by the NHMRC’s Research Committee to identify research topics requiring priority funding.  

NHMRC-AMED 2024 Collaborative Research Grant Scheme: Adopting Sustainable Partnerships for Innovation and Research Ecosystem (ASPIRE) funding outcomes announced

Grant outcomes for the 2025 NHMRC grant application round will be provided incrementally throughout the year. The outcome datasets may include a small number of schemes for which applications closed in the previous year.

Up until the mid-20th century there was little that clinicians could do to help a patient with renal (kidney) failure: the condition was fatal. By the late 1960s, however, advancements in medical research had made it possible to replace diseased kidneys with healthy ones through transplantation and to keep patients alive with dialysis until donor kidneys became available. NHMRC-funded clinician researchers played key roles in transforming kidney transplantation from an experimental procedure to a world-leading health care service for Australians with renal disease.

Worldwide, preterm birth (birth before 37 weeks) is the single largest cause of death in the newborn period and early childhood.1 In Australia each year, around 8% of babies (almost 26,000 in 2019)2 are born prematurely. A wide variety of health issues are associated with pre-term birth, including developmental delay, cerebral palsy, hearing and visual impairments, learning difficulties and psychiatric disorders. NHMRC-funded researchers at the South Australian Health and Medical Research Institute (SAHMRI) and other Adelaide-based institutions have made major contributions to reducing the prevalence of premature births and improving the health of premature babies.

Glaucoma is the leading cause of irreversible blindness worldwide, with an estimated 80 million people affected1 including more than 200,000 Australians.2 Over two decades, NHMRC-funded researchers at the Lions Eye Institute (LEI) and the University of Western Australia (UWA) developed a new approach that has revolutionised glaucoma treatment, leading to safer surgery and improved vision outcomes. With later support from an international industry team, this new glaucoma surgery is now in use worldwide.

MRFF – Clinical Trials Activity Initiative – 2025 International Clinical Trial Collaborations Grant Opportunity